Testimony
The following written comments were submitted to the Dockets Management Staff (HFA-305) Food and Drug Administration by IFFGD President, Ceciel T. Rooker, in response to Docket No. FDA-2019-D-4247 on December 30, 2019. Thank you for your leadership at the Center for Drug Evaluation and Research in the Food and Drug Administration (FDA). The International Foundation for […]
Testimony
IFFGD Vice-President, William Norton, submitted the following written public testimony to the FDA in connection with a January 11, 2012 meeting of the Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee to consider the premarket approval of the LINX Reflux Management System for the treatment of gastroesophageal reflux disease (GERD): On behalf […]
News Article
MOUNT PLEASANT, S.C., Dec. 1, 2025 /PRNewswire/ — This December for Constipation Awareness Month, IFFGD is shedding a light on common causes, prevention, and treatments. As well as promoting healthy conversations and lifestyle habits to support bowel movements. Constipation affects millions, approximately 1 out of every 6-7 people worldwide and annually leading to more than 1.5 million […]
Testimony
IFFGD President, Ceciel Rooker, submitted the following written statement to the House and Senate Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies regarding Fiscal Year (FY) 2020 appropriations for medical research and public health programs. April 9, 2019 STATEMENT OF CECIEL T. ROOKER PRESIDENT INTERNATIONAL FOUNDATION FOR […]
An_Introduction_to_Supplements_for_Gastrointestinal_Disorders.pdf
202_Think_It_Through_Managing_The_Benefits_And_Risks_Of_Medications.pdf
Cannabinoid Hyperemesis Syndrome (CHS) In this episode of 5 Minutes in GI, we sit down with Dr. Thangam Venkatesan and Dr. Benjamin Liu to discuss Cannabinoid Hyperemesis Syndrome (CHS). The original video has been split into two parts to make the content easily digestible (pun intended). This is part 2: Understanding CHS and Its Connection […]
Cannabinoid Hyperemesis Syndrome (CHS) In this episode of 5 Minutes in GI, we sit down with Dr. Thangam Venkatesan and Dr. Benjamin Liu to discuss Cannabinoid Hyperemesis Syndrome (CHS). The original video has been split into two parts to make the content easily digestible (pun intended). Understanding CHS and Its Connection to CVS Cannabinoid Hyperemesis […]